<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33239440</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Plasma microRNA signature in presymptomatic and symptomatic subjects with <i>C9orf72</i>-associated frontotemporal dementia and amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>485</StartPage><EndPage>493</EndPage><MedlinePgn>485-493</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2020-324647</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To identify potential biomarkers of preclinical and clinical progression in chromosome 9 open reading frame 72 gene (<i>C9orf72)</i>-associated disease by assessing the expression levels of plasma microRNAs (miRNAs) in <i>C9orf72</i> patients and presymptomatic carriers.</AbstractText><AbstractText Label="METHODS">The PREV-DEMALS study is a prospective study including 22 <i>C9orf72</i> patients, 45 presymptomatic <i>C9orf72</i> mutation carriers and 43 controls. We assessed the expression levels of 2576 miRNAs, among which 589 were above noise level, in plasma samples of all participants using RNA sequencing. The expression levels of the differentially expressed miRNAs between patients, presymptomatic carriers and controls were further used to build logistic regression classifiers.</AbstractText><AbstractText Label="RESULTS">Four miRNAs were differentially expressed between patients and controls: miR-34a-5p and miR-345-5p were overexpressed, while miR-200c-3p and miR-10a-3p were underexpressed in patients. MiR-34a-5p was also overexpressed in presymptomatic carriers compared with healthy controls, suggesting that miR-34a-5p expression is deregulated in cases with <i>C9orf72</i> mutation. Moreover, miR-345-5p was also overexpressed in patients compared with presymptomatic carriers, which supports the correlation of miR-345-5p expression with the progression of <i>C9orf72</i>-associated disease. Together, miR-200c-3p and miR-10a-3p underexpression might be associated with full-blown disease. Four presymptomatic subjects in transitional/prodromal stage, close to the disease conversion, exhibited a stronger similarity with the expression levels of patients.</AbstractText><AbstractText Label="CONCLUSIONS">We identified a signature of four miRNAs differentially expressed in plasma between clinical conditions that have potential to represent progression biomarkers for <i>C9orf72</i>-associated frontotemporal dementia and amyotrophic lateral sclerosis. This study suggests that dysregulation of miRNAs is dynamically altered throughout neurodegenerative diseases progression, and can be detectable even long before clinical onset.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT02590276.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kmetzsch</LastName><ForeName>Virgilio</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3691-0180</Identifier><AffiliationInfo><Affiliation>Inria, Aramis project-team, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anquetil</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracino</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Inria, Aramis project-team, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des d&#xe9;mences rares ou pr&#xe9;coces, IM2A, D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des d&#xe9;mences rares ou pr&#xe9;coces, IM2A, D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camuzat</LastName><ForeName>Agn&#xe8;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EPHE, PSL Research University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gareau</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jornea</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlani</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CMRR Service de Neurologie, CHU de Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallon</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Neurology and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquier</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Univ Lille, CHU, Inserm U1172, DISTALZ, LiCEND, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robil</LastName><ForeName>No&#xe9;mie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>GenoSplice, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Grange</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>GenoSplice, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moszer</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Ber</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des d&#xe9;mences rares ou pr&#xe9;coces, IM2A, D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Brain Institute - Institut du Cerveau - ICM, FrontLab, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colliot</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Inria, Aramis project-team, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Univ Rennes, Inria, CNRS, IRISA, F-35000 Rennes, France emmanuelle.becker@univ-rennes1.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PREV-DEMALS study group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02590276</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Neurosurg Psychiatry. 2021 May;92(5):458</RefSource><PMID Version="1">33722821</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Exome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: OC reports having received consulting fees from AskBio (2020), having received fees for writing a lay audience short paper from Expression Sant&#xe9; (2019), having received speaker fees for a lay audience presentation from Palais de la d&#xe9;couverte (2017) and that his laboratory has received grants from Qynapse (2017-present). Members from his laboratory have co-supervised a PhD thesis with myBrainTechnologies (2016-present). OC&#x2019;s spouse is an employee of myBrainTechnologies (2015-present). OC has submitted a patent to the International Bureau of the World Intellectual Property Organization (PCT/IB2016/0526993, Schiratti J-B, Allassonniere S, Colliot O, Durrleman S, A method for determining the temporal progression of a biological phenomenon and associated methods and devices) (2016). ILB served as a member of advisory boards for Prevail Therapeutic and received research grants from ANR, DGOS, PHRC, Vaincre Alzheimer Association, ARSla Association, Fondation Plan Alzheimer outside of the present work. PG is co-founder and director of GenoSplice. NR is employee at GenoSplice.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Benchetrit</LastName><ForeName>Eve</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bertrand</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bissery</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boncoeur</LastName><ForeName>Marie-Paule</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bombois</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camuzat</LastName><ForeName>Agn&#xe8;s</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chastan</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Yaohua</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chupin</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colliot</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delbeuck</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deramecourt</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delmaire</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerardin</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hossein-Foucher</LastName><ForeName>Claude</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubois</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Habert</LastName><ForeName>Marie-Odile</ForeName><Initials>MO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hannequin</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lautrete</LastName><ForeName>G&#xe9;raldine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lebouvier</LastName><ForeName>Thibaud</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ber</LastName><ForeName>Isabelle Le</ForeName><Initials>IL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toullec</LastName><ForeName>Benjamin Le</ForeName><Initials>BL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levy</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinaud</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martineau</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mackowiak</LastName><ForeName>Marie-Anne</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monteil</LastName><ForeName>Jacques</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasquier</LastName><ForeName>Florence</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petyt</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oya</LastName><ForeName>Assi-Herv&#xe9;</ForeName><Initials>AH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rametti-Lacroux</LastName><ForeName>Armelle</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Daisy</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rollin-Sillaire</LastName><ForeName>Adeline</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salachas</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sayah</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallon</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>26</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33239440</ArticleId><ArticleId IdType="pmc">PMC8053348</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2020-324647</ArticleId><ArticleId IdType="pii">jnnp-2020-324647</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456&#x2013;77. 10.1093/brain/awr179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Rademakers R, Neumann M. Tdp-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010;9:995&#x2013;1007. 10.1016/S1474-4422(10)70195-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245&#x2013;56. 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. . A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257&#x2013;68. 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Frick P, Neumann M. The neuropathology associated with repeat expansions in the C9orf72 gene. Acta Neuropathol 2014;127:347&#x2013;57. 10.1007/s00401-013-1232-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1232-4</ArticleId><ArticleId IdType="pubmed">24356984</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand A, Wen J, Rinaldi D, et al. . Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years. JAMA Neurol 2018;75:236&#x2013;45. 10.1001/jamaneurol.2017.4266</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4266</ArticleId><ArticleId IdType="pmc">PMC5838615</ArticleId><ArticleId IdType="pubmed">29197216</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kiernan M, Mitsumoto H, et al. . Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry 2014;85:1232&#x2013;8. 10.1136/jnnp-2013-307135</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307135</ArticleId><ArticleId IdType="pubmed">24648037</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso M, Piscopo P, Confaloni A, et al. . Circulating miRNAs as biomarkers for neurodegenerative disorders. Molecules 2014;19:6891&#x2013;910. 10.3390/molecules19056891</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules19056891</ArticleId><ArticleId IdType="pmc">PMC6271879</ArticleId><ArticleId IdType="pubmed">24858274</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider R, McKeever P, Kim T, et al. . Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 2018;89:851&#x2013;8. 10.1136/jnnp-2017-317492</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317492</ArticleId><ArticleId IdType="pmc">PMC6045452</ArticleId><ArticleId IdType="pubmed">29434051</ArticleId></ArticleIdList></Reference><Reference><Citation>Denk J, Oberhauser F, Kornhuber J, et al. . Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. PLoS One 2018;13:e0197329. 10.1371/journal.pone.0197329</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197329</ArticleId><ArticleId IdType="pmc">PMC5945001</ArticleId><ArticleId IdType="pubmed">29746584</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, et al. . Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain 2014;137:2938&#x2013;50. 10.1093/brain/awu249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011;12:99&#x2013;110. 10.1038/nrg2936</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2936</ArticleId><ArticleId IdType="pubmed">21245828</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 2010;7:420&#x2013;9. 10.4161/rna.7.4.12205</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.7.4.12205</ArticleId><ArticleId IdType="pubmed">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E, Gao F-B. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders. J Neurogenet 2014;28:30&#x2013;40. 10.3109/01677063.2013.876021</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2013.876021</ArticleId><ArticleId IdType="pmc">PMC4199862</ArticleId><ArticleId IdType="pubmed">24506814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wang J. Roles of extracellular microRNAs in central nervous system. ExRNA 2019;1:13. 10.1186/s41544-019-0011-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41544-019-0011-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohel MH. Extracellular/Circulating microRNAs: release mechanisms, functions and challenges. Achiev Life Sci 2016;10:175&#x2013;86. 10.1016/j.als.2016.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.als.2016.11.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinerman KS, Toledo JB, Tsivinsky VG, et al. . Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res Ther 2017;9:89. 10.1186/s13195-017-0316-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0316-0</ArticleId><ArticleId IdType="pmc">PMC5679501</ArticleId><ArticleId IdType="pubmed">29121998</ArticleId></ArticleIdList></Reference><Reference><Citation>Piscopo P, Grasso M, Puopolo M, et al. . Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia. J Alzheimers Dis 2018;65:455&#x2013;64. 10.3233/JAD-180364</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180364</ArticleId><ArticleId IdType="pubmed">30056425</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso M, Piscopo P, Talarico G, et al. . Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects. Neurobiol Aging 2019;84:240.e1&#x2013;240.e12. 10.1016/j.neurobiolaging.2019.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.01.024</ArticleId><ArticleId IdType="pubmed">30826067</ArticleId></ArticleIdList></Reference><Reference><Citation>Magen I, Yacovzada N, Warren JD, et al. . Classification and prediction of frontotemporal dementia based on plasma microRNAs. medRxiv 2020:2020.01.22.20018408.</Citation></Reference><Reference><Citation>Montembeault M, Sayah S, Rinaldi D, et al. . Cognitive inhibition impairments in presymptomatic C9orf72 carriers. J Neurol Neurosurg Psychiatry 2020;91:366&#x2013;72. 10.1136/jnnp-2019-322242</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322242</ArticleId><ArticleId IdType="pubmed">32054668</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res 2017;27:491&#x2013;9. 10.1101/gr.209601.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.209601.116</ArticleId><ArticleId IdType="pmc">PMC5340976</ArticleId><ArticleId IdType="pubmed">28100584</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011;17:10&#x2013;12. 10.14806/ej.17.1.200</Citation><ArticleIdList><ArticleId IdType="doi">10.14806/ej.17.1.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Trapnell C, Pop M, et al. . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009;10:R25. 10.1186/gb-2009-10-3-r25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2009-10-3-r25</ArticleId><ArticleId IdType="pmc">PMC2690996</ArticleId><ArticleId IdType="pubmed">19261174</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, et al. . The sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078&#x2013;9. 10.1093/bioinformatics/btp352</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. featureCounts: an efficient General purpose program for assigning sequence reads to genomic features. Bioinformatics 2014;30:923&#x2013;30. 10.1093/bioinformatics/btt656</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedl&#xe4;nder MR, Mackowiak SD, Li N, et al. . miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 2012;40:37&#x2013;52. 10.1093/nar/gkr688</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr688</ArticleId><ArticleId IdType="pmc">PMC3245920</ArticleId><ArticleId IdType="pubmed">21911355</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139&#x2013;40. 10.1093/bioinformatics/btp616</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-Seq data. Genome Biol 2010;11:R25. 10.1186/gb-2010-11-3-r25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2010-11-3-r25</ArticleId><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, et al. . Scikit-learn: machine learning in python. J Mach Learn Res 2011;12:2825&#x2013;30.</Citation></Reference><Reference><Citation>Vlachos IS, Zagganas K, Paraskevopoulou MD, et al. . DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 2015;43:W460&#x2013;6. 10.1093/nar/gkv403</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv403</ArticleId><ArticleId IdType="pmc">PMC4489228</ArticleId><ArticleId IdType="pubmed">25977294</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson RAK, Fernandez-Martos CM, Atkin JD, et al. . C9Orf72 expression and cellular localization over mouse development. Acta Neuropathol Commun 2015;3:59. 10.1186/s40478-015-0238-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0238-7</ArticleId><ArticleId IdType="pmc">PMC4582620</ArticleId><ArticleId IdType="pubmed">26408000</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Konopka A, Soo KY, et al. . The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet 2017;26:2882&#x2013;96. 10.1093/hmg/ddx170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, et al. . C9Orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 2020;582:89&#x2013;94. 10.1038/s41586-020-2288-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J, Peng L, Tao T, et al. . Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomed Pharmacother 2019;119:109409. 10.1016/j.biopha.2019.109409</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109409</ArticleId><ArticleId IdType="pubmed">31518873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua CEL, Tang BL. miR-34A in neurophysiology and neuropathology. J Mol Neurosci 2019;67:235&#x2013;46. 10.1007/s12031-018-1231-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1231-y</ArticleId><ArticleId IdType="pubmed">30488149</ArticleId></ArticleIdList></Reference><Reference><Citation>Cos&#xed;n-Tom&#xe1;s M, Antonell A, Llad&#xf3; A, et al. . Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer&#x2019;s Disease: Potential and Limitations. Mol Neurobiol 2017;54:5550&#x2013;62. 10.1007/s12035-016-0088-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0088-8</ArticleId><ArticleId IdType="pubmed">27631879</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg MMJ, Krauskopf J, Ramaekers JG, et al. . Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol 2020;185:101732. 10.1016/j.pneurobio.2019.101732</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.101732</ArticleId><ArticleId IdType="pubmed">31816349</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Cheng Y, Zhang Y, et al. . Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J Neurochem 2012;123:477&#x2013;90. 10.1111/j.1471-4159.2012.07925.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07925.x</ArticleId><ArticleId IdType="pmc">PMC3472040</ArticleId><ArticleId IdType="pubmed">22906125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauhari A, Singh T, Singh P, et al. . Regulation of miR-34 family in neuronal development. Mol Neurobiol 2018;55:936&#x2013;45. 10.1007/s12035-016-0359-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0359-4</ArticleId><ArticleId IdType="pubmed">28084588</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi PK, Jaiswal S, Sharma P. Regulation of neuronal cell cycle and apoptosis by microRNA 34a. Mol Cell Biol 2016;36:84&#x2013;94. 10.1128/MCB.00589-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00589-15</ArticleId><ArticleId IdType="pmc">PMC4702589</ArticleId><ArticleId IdType="pubmed">26459758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A, Leonardis L, Zidar J, et al. . Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep 2018;8:5609. 10.1038/s41598-018-23139-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId><ArticleId IdType="pmc">PMC5884852</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocerha J, Kouri N, Baker M, et al. . Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. BMC Genomics 2011;12:527. 10.1186/1471-2164-12-527</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-12-527</ArticleId><ArticleId IdType="pmc">PMC3229715</ArticleId><ArticleId IdType="pubmed">22032330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin AS, Unger TL, Gallagher MD, et al. . Tmem106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J Neurosci 2012;32:11213&#x2013;27. 10.1523/JNEUROSCI.0521-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0521-12.2012</ArticleId><ArticleId IdType="pmc">PMC3446826</ArticleId><ArticleId IdType="pubmed">22895706</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert SS, Wang W-X, Zhu Q, et al. . A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with Lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis 2013;35:335&#x2013;48. 10.3233/JAD-122350</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-122350</ArticleId><ArticleId IdType="pmc">PMC3753694</ArticleId><ArticleId IdType="pubmed">23403535</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E, Lynch K, Ruan H, et al. . Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia. Nat Med 2014;20:1444&#x2013;51. 10.1038/nm.3717</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3717</ArticleId><ArticleId IdType="pmc">PMC4257887</ArticleId><ArticleId IdType="pubmed">25401692</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Woldemichael BT, Kremer EA, et al. . Memory decline and its reversal in aging and neurodegeneration involve miR-183/96/182 biogenesis. Mol Neurobiol 2019;56:3451&#x2013;62. 10.1007/s12035-018-1314-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1314-3</ArticleId><ArticleId IdType="pubmed">30128653</ArticleId></ArticleIdList></Reference><Reference><Citation>Helferich AM, Brockmann SJ, Reinders J, et al. . Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cell Mol Life Sci 2018;75:4301&#x2013;19. 10.1007/s00018-018-2873-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2873-1</ArticleId><ArticleId IdType="pubmed">30030593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A, Thomas MP, Altschuler G, et al. . Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet 2011;7:e1002363. 10.1371/journal.pgen.1002363</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002363</ArticleId><ArticleId IdType="pmc">PMC3213160</ArticleId><ArticleId IdType="pubmed">22102825</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, et al. . Micro-Rnas secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine 2019;40:626&#x2013;35. 10.1016/j.ebiom.2018.11.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Boese AS, Saba R, Campbell K, et al. . Microrna abundance is altered in synaptoneurosomes during prion disease. Mol Cell Neurosci 2016;71:13&#x2013;24. 10.1016/j.mcn.2015.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.001</ArticleId><ArticleId IdType="pubmed">26658803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>